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ABSTRACT 
Recessive Dystrophic Epidermolysis Bullosa (RDEB) is a severe skin disorder produced 
by a mutation in the COL7A1 gene (c.6527inC) and leads to dysfunctional or absent 
collagen type VII in the dermo-epidermal junction. Consequently, blisters appear 
throughout the body, including mucous membranes. Currently, diagnosis is routinely 
performed by rubbing the skin to induce a blister and taking a biopsy for histological 
analysis. Mutational analysis is possible but it is expensive and difficult. In this work, a 
suction device has been developed to substitute the current RDEB diagnostic method 
by a more precise, reproducible and reliable one. An easy to use device represents a 
less invasive method of diagnosis that betters the life of patients that may have severe 
conditions such as RDEB. The principal characteristics of the device are its small size 
and manageability. It is equipped with a vacuum pump for suctioning, connected to a 
pressure sensor, an OLED screen to provide real-time reading of the sensor, and an 
incandescent light bulb to provide heat. The device can be turned on and off by a simple 
pushbutton, and the suction modulated. It is operated by an Arduino-compatible 
microcontroller. To obtain the combination of pressure and time needed for blister 
generation, RDEB human skin mice models were developed using human plasma 
scaffolds as dermal component. Applying a negative pressure of 80-85 kPa for 5 minutes 
produced a well-defined blister at the DEJ, without damaging the dermis. Results were 
confirmed by Hematoxylin and Eosin staining and immunohistochemical studies of 
collagen VII, vimentin and cytokeratins 10 and 14. Temperature influenced blister 
generation. Higher negative pressures proved to cause dermal disruption, with DEJ and 
intradermal blistering, as well as tissue deformation. Epidermis remained intact in all 
cases. To complement this work and explore one of the possible applications of the 
device, the result was tested on a skin model corrected for the COL7A1 gene mutation 
that was provided by another research group. Collagen VII was observed, and tissue 
architecture was conserved after suction without dermal disruption or blisters. In 
conclusion, determining blistering times for EB represents a great advance in the 
diagnosis of the disorder. Helping such patients determine their condition may greatly 
influence their cures. In addition, the data obtained may help in develop specific 
treatments for the different types and subtypes of RB, including RDEB.  
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1. INTRODUCTION 
1.1. Motivation and Objectives 
The diagnosis of Epidermolysis bullosa is standardly performed taking a biopsy of a 
freshly induced blister in the patient, generated by rubbing the skin, and analysis using 
immunohistochemical methods and electron microscopy. Mutational analysis can be 
performed to make an exact diagnosis, but it is expensive and not easily accessed. This 
project arose from the need for a more accurate and standardized method for generating 
blisters in a controlled manner that could be reproducible and available for clinical use.  
In this work, the plan was to develop a method of diagnosis by exerting a vacuum force 
on the skin and creating a blister by means of a simple device. This was created with the 
functionalities needed for the diagnosis of EB, and in a shape and size for it to be 
manageable and easy to carry. An apparatus with good characteristics was found, and 
the casing was taken from it, while the other elements would be introduced and modified 
to achieve the final product.  
In order to test the parameters of blister generation, an in vivo experiment was designed, 
with human skin grafts developed in culture and transplanted into immunodeficient mice. 
To confirm the hypothesis, in addition to visual proof, histological and 
immunohistochemical analyses were made.  
1.2. Background 
1.2.1. The Skin 
The skin is the largest organ in the human body, accounting for almost 2 m2 of its surface 
and up to 20 % of its total weight, with variable thickness throughout. Also known as the 
integument, its functions include protection, support, regulation, communication and 
synthesis. It provides a physical barrier against mechanical and thermal damage, as well 
as being selectively permeable and balancing the water homeostasis. Additionally, it 
protects the body from pathogens like microorganisms and other substances and 
initiates the immune response whenever these go through. The skin has many different 
sensory receptors all over the body, to detect changes in the environment and regulate 
the body accordingly. More specifically, this organ has several thermoregulation 
mechanisms to maintain a constant temperature. Furthermore, the skin has metabolic 
functions such as excretion of excess metabolites, vitamin D synthesis, and energy 
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storage [1]. A simplified representation of the main structures of this organ can be seen 
in Figure 1. 
 
Figure 1: Schematic representation of the skin showing major layers, representative 
structures and vascularization. Hair follicles are present from the dermis up to the outermost 
layer, as well as glands and sensory receptors. Along the junction between the dermis and 
epidermis, two structures can be identified: epidermal ridges and dermal papillae. Their 
function is to strengthen the union. [1] 
 
The skin requires basic features that are present in almost every tissue. The mechanical 
strength necessary is provided by an extracellular matrix, which is secreted by the cells 
in the tissue. To obtain nutrients and oxygen, as well as removing waste products, a 
network of blood and lymphatic vessels is needed. These vessels also protect the tissue 
against infections by providing access to the immune system. Additionally, nerve fibers 
are present to carry information from the sensory receptors of the tissue to the central 
nervous system, and to deliver signals for muscle contraction or glandular secretion [2]. 
The skin consists of two types of tissue: epithelia, corresponding to the epidermis, and 
connective tissue, corresponding to the dermis and subcutaneous layer.  
a) Epidermis 
The epidermis is the most external layer of the skin, in contact with the environment. It 
is a stratified squamous keratinized epithelium composed of keratinocytes. Their name 
comes from their characteristic keratin intermediate filaments, which contribute to the 
tissue’s strength. These cells do not produce extracellular matrix and are tightly bound 
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together by a variety of cellular mechanisms. The epithelium does not contain blood 
vessels, lymphatic vessels or nerve fibers, so it needs a supporting tissue to nourish it 
(connective tissue), as well as efficient communications and diffusion mechanisms 
between cells.  
The epidermis has several layers or stratums (Figure 2), characterized by the shape of 
the cells and their stages of differentiation on each of them. The innermost layer, or 
basal, is composed of cuboidal or columnar cells set on top of the basement membrane. 
This structure is a thin, organized layer of extracellular matrix, secreted by the dermis’ 
cells, underlying epithelia. It has adhesive, filtering and barrier properties, and limits the 
epidermis from the dermis. The basal stratum is characterized by keratinocytes with high 
mitotic activity and presence of progenitor cells (adult stem cells) to regenerate the 
tissue. In humans, this regeneration occurs every 15 to 30 days, depending on the age 
and location in the body. The next stratum is the spinous layer, with polyhedral cells that 
make up for the most part if the epidermis, especially on the epidermal ridges (Figure 1, 
Figure 2).  
The granular layer is composed of flattened cells tightly sealed together, with their 
characteristic keratohyalin granules, grains composed of keratins and histidin-rich 
proteins. Keratinocytes of the granular and upper spinous layers have lamellar granules, 
that liberate lipidic substances to create a hydrophobic coat on the membrane and block 
penetration of external substances. Cells in this layer are in the final stages of 
differentiation, going through the keratinization process.  
Finally, the two outermost layers, stratum lucidum and stratum corneum, consist of 
flattened cells that have lost almost or all their organelles and nucleus. Their cytoplasm 
is filled with a mesh of keratin filaments and other cross-linked proteins (involucrin, 
loricrin, and others), and they are shed at the skin surface. Stratum lucidum is only found 
in thick skin, while stratum corneum is present in the whole body surface [1], [2], [3].  
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Figure 2: Diagram representing the epidermis 
and its layers. [1] 
 
An important feature of this tissue is the intracellular adhesion. There are several 
structures that maintain tissue integrity by joining and communicating epidermal cells. 
Tight junctions seal adjacent cells laterally by two transmembrane proteins, claudin and 
ocludin, reinforcing the epidermis’ selective permeability by ensuring molecules only 
pass the tissue through the cells. Adherent junctions bind the cells similarly through 
cadherins, attached to the cytoskeleton. Both structures encircle the apical ends of 
epithelial cells. Desmosomes are spot junctions in a circular shape that appear in the 
cytoplasmic side of each cell’s membrane. Cadherins connect the two plaque-like 
structures (composed mainly of desmoplakin and plakoglobin), that are anchored to the 
IF. Hemidesmosomes look similar, except they join the cell to the basal membrane, by 
means of mostly integrins that bind extracellular proteins. Finally, gap junctions are 
adhesions that double as communication paths between cells. Transmembrane proteins, 
connexins, aggregate into circular patches in the plasma membrane, forming small 
hydrophilic pores for intercellular exchange of molecules [1].  
• Keratins, Intermediate Filaments and Keratinization in the Epidermis 
Intermediate Filaments (IF) are chemically stable, long and unbranched components 
of the cytoskeleton in cells. These structures have a high cell-type specific protein 
composition, and keratins are the IF proteins of the epithelial tissue. They span 
through the cytoplasm and attach to the characteristic cell-cell adhesion structures in 
the tissue: desmosomes and hemidesmosomes [4]. Keratin IFs provide mechanical 
stability and structure to the cells and tissue (cell-cell junctions and adhesion to 
basement membrane), as well as certain signaling functions. Keratins have been 
classified according to the chromosomal site of their encoding genes into types I and 
II [5]. During epidermal differentiation, keratinocytes move upward, transitioning from 
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the proliferative basal layer to the post mitotic suprabasal layers, undergoing the 
keratinization process. The types of keratin filaments and their expression changes 
up to the superficial cells, in which keratins are half of the total protein mass. In the 
basal layer, IFs composed of K5/K14 IF bundles are predominant along the 
undifferentiated basal keratinocytes and are also present in further differentiation 
stages along the lower suprabasal epidermal layers. K1 and K10 are the major 
proteins in keratinocyte differentiation and keratinization and form denser bundles 
along the suprabasal layers (spinous, granular, stratum corneum). They are involved 
in structural stability and mechanical strength as well as other functions such as 
inhibition of keratinocyte proliferation by K10 [6].  
b) Dermis 
The dermis consists of two non-delimited sublayers of simple connective tissue below 
the epidermis. This type of tissue is composed of non-polarized cells, fibroblasts, 
immerse in extracellular matrix (ECM). These cells are in charge of secretion of collagen 
and elastin, main components of the connective tissue ECM. The dermis carries blood 
and lymph vessels and nerves, and provides structural support to the epidermis (Figure 
3). The extracellular matrix includes a collagen and elastic network and a ground 
substance of carbohydrates and proteins (glycosaminoglycans, proteoglycans and other 
adhesive glycoproteins). The large complex molecules of the ground substance 
osmotically attract water to the tissue resulting in swelling (turgor). Pressure from turgor 
helps the ECM resist compressive forces [7]. The collagen fibers present in the dermis 
are many, but the most abundant are type I, III and V. Other collagen types influence the 
network’s characteristics, according to the specific intra-tissue localizations.  
 
Figure 3: Diagram representing the dermis 
and its layers. [1] 
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The contact surface with the epidermis is uneven and characterized by the presence of 
dermal papillae (Figure 1), opposite to the epidermal ridges. Its thickness depends on 
the area of the body, and can reach a maximum of 4 mm. The uppermost layer is called 
papillary layer, and is made of loose connective tissue, including types I and III collagen 
fibers. The cells present in this area are fibroblasts and scattered mast cells, 
macrophages, and other leukocytes. Additionally, collagen VII anchoring fibers insert into 
the basement membrane and join the two tissues. The reticular layer of the dermis is a 
thicker dense connective tissue area, with mainly type I collagen [1], [7]. 
c) Dermal-Epidermal Junction 
Skin integrity is guaranteed by the appropriate attachment of the epidermis to the dermis. 
The Dermal-Epidermal Junction (DEJ) plays a crucial role as an anchoring site of both 
tissues. It can be considered as four units, characterized by the expression of different 
protein components. These units are included within the epidermal cells, the basement 
membrane, and the dermis.  
The basement membrane (BM) is a sheet of extracellular matrix composed of 
glycoproteins. The upper layer, closer to the epidermis and secreted by its cells, is called 
lamina lucida. Below, the lamina densa is the layer produced by dermal cells. The 
functions of the BM are diverse. It provides structural support and polarity to basal 
epithelial cells and attaches them to the dermis. In addition, it affects epithelial cell 
membrane organization, as well as mediating their interactions and migration. It also 
filters and accumulates substances from the dermis to the epidermis.  
A schematic diagram of the proteins involved in the DEJ and their location within the 
tissues is shown in Figure 4.  
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Figure 4: Dermal-Epidermal Junction. Schematic representation corelated to a histological image of the 
skin. Four domains of DEJ: basal cell layer, lamina lucida, lamina densa, sub-lamina densa. Main 
components in this structure and the related proteins are listed (desmosomes, hemidesmosomes, 
anchoring filaments and fibrils). [8] 
 
First, the structure within the basal keratinocytes that binds them, and the epidermis, to 
the dermis is the hemidesmosome. This structure is composed of intracellular and 
transmembrane proteins. Plectin, an intracellular protein, connects keratin intermediate 
filaments (K5/K14 bundles) to transmembrane integrins (α6β4) and collagen XVII fibers. 
Through the lamina lucida, laminins (332) bind hemidesmosomes to collagen IV in the 
lamina densa. Underneath the lamina densa, collagen types III and VII in the anchorin 
fibrils secure this structure to the dermal network. Moreover, there is another protein 
complex that plays a role in DEJ, at the interface between the basal keratinocyte layer 
and lamina lucida. Kindlin-1, complemented with integrin α3β1, joins intracellular 
filaments of actin to a laminin in the lamina lucida. 
1.2.2. Inherited Epidermolysis Bullosa 
Epidermolysis bullosa (EB) refers to a group of diverse genetic disorders in a variety of 
structural proteins of the skin, that fall into the category of mechanobullous 
genodermatoses. The variants of 20 genes have been known to cause the different types 
and subtypes of EB [9]. As a result of said mutations, these disorders can involve 
alterations such as simple molecular defects or lack of key adhesion proteins. The 
characteristic phenotypes are variable, and range from tissue fragility on mechanically 
exposed sites as hands and feet, to formation of blisters and wounds such as those seen 
in Figure 5, all in response to mechanical trauma [10]. The genes involved are expressed 
in other epithelia of the body, such as the gastrointestinal, urinary, respiratory or skeletal 
systems.  
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Figure 5: Epidermolysis bullosa phenotypes. The disease can have diverse effects. (a) Localized 
blistering and erosions on skin exposed to mechanical forces (hands, feet). (b) Generalized blisters, 
erosions and exposed skin all over the body, lethal type of epidermolysis. [11] 
 
The incidence of this disease is approximately half a million patients worldwide [12], and 
according to the Orphanet database, the prevalence of this disease is of 1-9 over a 
million [13]. In the United States, the incidence is of nearly 1/53000 live births, and 
1/125000 of prevalence –with similar data in several European countries. According to 
this, EB is considered as a rare disease (RD), which affect only small numbers of 
individuals (5 out of every 10000 or less) [14]. The issue with these conditions is that, 
due to the low incidences and the complex origins, the research dedicated to them is 
scarce and scattered throughout different countries. Consequently, there are few specific 
health policies dedicated to them, and diagnosis is difficulted, as well as access to 
treatment or care. 
The classification of the diverse types of EB has been changing throughout the years 
since it was first reported with such name in 1886. Along with the discovery of new 
technologies and techniques, the data available kept bringing light into what were the 
underlying causes of the symptoms observed. At first, the focus was on distinguishing 
between the inherited and acquired forms of EB, and later on the three major types were 
established – simplex, junctional and dystrophic. This first classification was based on 
the degree of tissue separation observed. The development of immunofluorescence 
techniques and other protein analysis methods allowed for the detection of certain 
molecules involved in EB, along with a proper diagnosis.  
The progress in genetics of the 1990s (DNA sequencing, gene mapping and cloning) 
enabled the discovery of the underlying mutations causing these molecular malfunctions 
[15]. From that, mostly subtypes of EB were identified, and other genodermatoses were 
included, such as Kindler syndrome. The progress was reported in the International 
Consensus Meetings on Diagnosis and Classification of Epidermolysis bullosa, the last 
(a) (b) 
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one to date being the third in 2008 [16]. Although the classification has progressed 
significantly, even more mutated genes, mutation mechanisms and phenotypes are 
emerging.  
Four types of EB are distinguished within the allelic heterogeneity of the disease, each 
characterized by the location and protein causing the cleavage in the skin, shown in 
Figure 6. Epidermolysis bullosa Simplex (EBS), with intraepidermal cleavage; Junctional 
(EBJ), where the skin breaks in the lamina lucida of the basement membrane; Dystrophic 
(RDEB) with breakage below the basement membrane (anchoring fibrils); and Kindler 
syndrome (KS), with variable location of cleavage. Furthermore, EB types are identified 
according to other criteria such as clinical severity, inheritance pattern (dominant or 
recessive), relative protein expression and type of gene mutation [9].  
 
 
Figure 6: (a)Immunofluorescence staining of normal human skin with antibodies to demsoplakin, 
collagen VII and nuclei and EB types indicating their respective levels of breakage. [15] (b) 
Representation of the proteins affected in different types of inherited epidermolysis bullosa. [17] 
 
• Epidermolysis bullosa Simplex (EBS) affects the epidermal layer. It is the most 
common type and it is inherited in an autosomal dominant manner. Two EBS 
groups can be distinguished, depending on where on the epidermis the mutated 
protein is mostly expressed. Suprabasal EBS affects proteins within cell-cell 
adhesions such as desmosomal plakoglobin or desmoplakin. The disorder does 
(a) 
(b
) 
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not manifest with clear blisters, but with erosions or increased desquamation due 
to fragility of keratinized cells. Basal EBS is mostly caused by mutations on the 
keratin 5 and 14 encoding genes. Hence, the cells are partially or completely 
unable to form keratin intermediate filaments, and cytoskeleton destabilization 
and cytolysis occur.  
• On Junctional Epidermolysis bullosa (JEB) the blistering appears on the 
lamina lucida, and it is normally inherited as autosomal recessive. Localized and 
generalized subtypes can be distinguished. Herlitz JEB is a generalized variant 
that affects laminin-332, with blistering on extensive mucocutaneous surfaces 
present from birth. The mortality rate is 100% on the first years of life, due to 
severe complications such as pneumonia, airway obstruction and sepsis. Other 
subtypes (Generalized intermediate JEB) present high risk of squamous cell 
carcinoma.  
• Dystrophic Epidermolysis bullosa (DEB) appears with mutations on the 
COL7A1, coding for collagen VII, and it is inherited as autosomal dominant or 
recessive. These mutations affect the structural integrity of anchoring fibrils, so 
the blistering appears between the dermis and epidermis, below the basement 
membrane. In severe cases, complete protein loss occurs, with extreme skin 
fragility, scarring, mutilations, malnutrition or growth retardation as disease 
complications.  
• Kindler syndrome (KS) is a genodermatosis included in the EB groups, 
characterized by the mutation of the gene FERMT1, which codes for kindlin-1. 
This protein anchors basal keratinocytes to the actin filaments of the 
cytoskeleton. KS causes blisters in childhood, as well as other complications skin 
atrophy, photosensitivity, gingivitis, periodontitis, and other urogenital and 
gastrointestinal issues. Moreover, nonmelanocytic skin tumors can appear in KS 
patients.  
For further reference, all known types and subtypes of EB are listed in ANNEX 
accompanied by their corresponding inheritance patterns, mutated genes and affected 
proteins.  
In the following subsection Recessive Dystrophic Epidermolysis bullosa, the subtype 
employed in this work, is described in detail. 
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1.2.3. Recessive Dystrophic Epidermolysis Bullosa 
a) Description 
Recessive Dystrophic Epidermolysis bullosa is one of the two main subtypes of DEB, 
and one of the most severe EB types. It is caused by a recessively inherited mutation in 
the COL7A1 gene, which can lead to aberrant synthesis or defective assembly of 
Collagen type VII (C7). In consequence, anchoring fibrils in the dermal-epidermal 
junction partially or completely lose their adherent function. Due to the genotypical 
heterogeneity of mutations in COL7A1 gene, this disorder can give rise to many 
phenotypes and clinical manifestations.  
Being recessively inherited, this disorder is characterized by the presence of mutations 
in both alleles of the gene, each inherited from one parent. These can be missense or 
nonsense mutations, combined between the two alleles, which explain the clinical 
variations observed within RDEB. The two most common subtypes are Generalized 
Severe (GS) and Generalized Other (GO). RDEB-GS appears when a premature 
termination codon mutation is present in both gene alleles, which gives rise to abnormally 
truncated polypeptides incapable of forming C7, that degrade inside the cell before 
forming anchoring fibrils. In RDEB-GO, one allele has a premature termination codon, 
while the other has a missense mutation. The cells are able to produce a somewhat 
functioning form of C7, structurally abnormal, that gives rise to a milder disease variety. 
In addition, other elements such as cytokines have been identified to affect RDEB 
phenotypes. 
The clinical manifestations of RDEB-GS and GO are similar, the latter being milder as 
there is C7, even if not fully functional. RDEB manifests in the skin with mutilating 
scarring and blistering. Moreover, symptoms appear in mucous membranes, as 
esophageal strictures (leading to malnutrition and slowed growth), pseudosyndactly 
(fused fingers and toes due to progressive scarring), loss of nail plates, joint contractures, 
eye inflammation and visual impairment [18]. In addition, RDEB forms have been related 
to the development of squamous cell carcinoma (SCC) [19]. 
b) Diagnosis 
Currently, the diagnosis of EB involves studying patient’s history, course of the disease, 
and histopathology and electron microscopy examination, as well as a genetic study. 
The first step is to take a biopsy from a freshly induced blister in a clinically normal area 
of the patient’s skin. Existent wounds do not ensure accurate results due to possible re-
epithelialization under blister roof and degradation of important proteins during 
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inflammatory immune response. The skin is rubbed applying torsion with a pencil eraser 
or until the area turns red, and the punch biopsy is taken. For less severe EB patients 
such as EBS or dominant DEB, prolonged (up to 3 hours) torsion force may be required 
for inducing a new blister [20].  
Transmission Electron Microscopy (EM) is considered the gold standard laboratory test 
for differentiation between the various forms of EB. This technique provides means for 
visualization of ultra-structural abnormalities and gives semi-quantitative information 
about structural deficits. For EBS or DEB, where issues may arise from morphological 
abnormalities in intermediate filaments, EM may be particularly useful to detect 
abnormalities that immunohistochemical analyses cannot detect. Nevertheless, EM is an 
expensive and time-consuming technique, and nowadays not so many laboratories can 
provide accurate results, as it requires an extensive training period. 
Immunohistochemistry offers a diagnostic with comparable precision to EM. It is simpler, 
more convenient and faster both to perform and to interpret, and less expensive. With 
the use of specific monoclonal antibodies, it can provide information about the most likely 
mutated structural protein as well as the EB type [21].  
However, the most effective method for detection of the inherited gene defect(s) is 
mutational analysis. It allows to predict clinical severity, phenotype, and natural history 
of the disease, as well as the mode of inheritance and chances of recurrence in offspring. 
Techniques for mutational analysis include Next Generation Sequencing (NGS), 
genotyping of Sanger sequencing for known mutations, variants or even genes (as 
COL7A1); multigene panel testing, RNAseq, PCR in cases where no specific information 
is available; and whole exome or genome sequencing [9]. 
c) Treatment 
Nowadays, this disorder can be managed with multidisciplinary palliative wound care 
and trauma minimization, complemented with support groups such as DEBRA 
(Dystrophic Epidermolysis Bullosa Research Association). In addition, due to the high 
risk of SCC, skin cancer screenings must be regularly performed on the patient.  
However, many therapies are being researched and developed with promising results, 
not yet brought to the clinical application. For information about ongoing clinical trials, 
there are many up to date references such as Clinicaltrials.gov from the United States 
National Library of Medicine or the European Union Clinical Trials Register.  
Some of the most significative therapies are briefly explained in the following lines: 
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• Gene therapy consists on correcting the altered genome by transferring a 
functional version through a viral vector. The target must be stem cells (in the 
case of EB epidermal stem cells), for the tissue to develop correctly after 
renovation. The newly functional cells are grafted into a fresh wound in the tissue 
as call sheets or skin equivalents. Gene therapy presents two major drawbacks. 
First, the skin regeneration is difficult in certain body parts, such as mucous 
membranes or gastrointestinal surfaces. Second, there is a chance of developing 
an immune reaction to the collagen produced by genetically corrected cells, 
especially in RDEB forms where C7 is not present at all [18]. Additionally, the risk 
of adverse mutagenic effects increases with the use of vectors capable of long-
term gene expression, adding on to the risk of SCC that RDEB patients have.  
Gene editing mechanisms use site-specific molecule complexed to cleave the 
DNA helix and introduce the desired genetic code in the generated space. 
CRISPR/Cas9 is a two-component system composed of a nuclease (Cas9) that 
conjugates with a small RNA transcript (gRNA) that serves as a guide. This 
complex targets a complementary DNA sequence consisting of 15–
20 nucleotides. Once the desired DNA break is generated, genome modification 
by homology-directed repair (HDR) is done, precisely inserting donor DNA into 
the targeted site. It allows for specific, efficient gene editing with possible in vivo 
applications [22]. 
Revertant mosaicism is a «natural gene therapy» mechanism found in several 
organisms, where the disease-causing mutation is locally corrected. This 
happens through postzygotic somatic molecular events such as second-site 
mutations or homologous recombination. Initially, it was thought to be a rare 
occurrence, but in EB it has been reported in all types in different genes [23].  
• Fibroblast cell therapy consists on injecting the patient with fibroblasts from 
healthy donors intradermally. This treatment has been demonstrated to have 
several months of duration in which partially functional anchoring fibrils are 
present [24]. It is suitable for milder disorder manifestations.  
• Mesenchymal stem cell (MSC) therapy is based on intravenous or intradermal 
injections of these cells into EB patients. Benefits have been reported in several 
clinical trials –with children and adults– including better wound healing, 
decreased blistering, less skin pain, or presence of functional anchoring fibrils. 
However, the mechanisms of action of MSCs are yet to be determined. It is 
probable that their capabilities of mediating immunosuppressive and 
immunoregulatory effects are the cause for patient improvement, rather than the 
1. INTRODUCTION 
 
14 
 
de novo synthesis of C7. When grafted into HLA-compatible patients, the 
likelihood of graft versus host disease and other immune responses is low. 
Furthermore, the possibility of targeting endogenous MSCs with gene therapy is 
being researched, to allow the body to produce progenitors capable of proper 
wound healing [25].  
Cell therapy and gene editing procedures can be combined to give rise to 
genetically corrected autologous cells to be implanted or injected in the patient 
for long-time restoration of function. An example of such therapy can be seen in 
[26]. 
• Another future treatment is protein therapy. Injecting intradermally purified C7 
human protein into RDEB mice models has been proven successful, with 
anchoring fibril formation and consequent enhanced dermoepidermal adherence. 
For more generalized cases, intravenous injections can be done. Some 
drawbacks exist to this treatment method. Due to degradation of the protein, 
repeat injections would be needed after a certain amount of time. Also, the 
immune response to foreign C7 is yet to be determined [18]. 
1.2.4. Plasma as a Dermal Scaffold for Skin Grafts 
The skin grafts used for transplant in this project were generated in cell culture using 
human plasma as the dermal component.  
Bioengineered skin grafts have been developed for treatment of skin diseases and 
applied to different fields. They can be introduced to restore burnt or ulcerated tissue, 
created to locally or systemically deliver therapeutics, or used as a realistic model to 
replace animal-based tests in drug development or toxicological assessment. Modeling 
skin diseases in a humanized context is crucial for understanding disease mechanisms. 
In addition, disease modeling in vivo enables preclinical studies potentially positive for 
the clinical outcome. For this purpose, cells obtained from skin biopsies can be expanded 
in vitro and assembled in three-dimensional matrices to develop skin equivalents (Figure 
7).  
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Figure 7: Simplified representation of generation of disease human skin models in vivo [27]. 
 
Previous works ([27], [28], [29]) have developed a method for successful skin model 
generation and grafting onto the back of immunodeficient mice. Skin of human origin is 
regenerated, vascularized and innervated by mouse vessels and nerves. The result was 
healthy and mature skin preserving human tissue architecture that persisted after several 
epidermal turn-overs, demonstrated by immunohistochemical assays during follow-up 
periods. Human keratinocytes and/or fibroblasts are selected from the patient to replicate 
the desired conditions. In addition, cells can be genetically manipulated to express or 
silence preferred genes, generating transgenic or KO humanized-skin respectively. 
Gene therapy approaches in combination with the bioengineered skin humanized mouse 
model constitute a robust platform to conduct preclinical studies. 
1.2.5. Suction Device 
The final product was developed from an already existing apparatus, to conserve its 
shape and manageability. The original appearance can be seen in Figure 8. This device 
functioned discretely and had no control unit to regulate its operation mode. 
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Figure 8: Original device. Blackhead remover from brand Beauty Nymph. Amazon.es 
 
To modify the device, the most essential step was including the Arduino Nano controller, 
which can be later programmed to provide all the functionalities needed. The element 
that exerts the force is a vacuum pump, and to control its intensity, a potentiometer is 
used. To turn the device on and off, a push button was introduced, with a connection to 
a digital input in the Arduino. The project is based on exerting pressure on the skin to 
generate blisters, so knowing how much the device is applying is crucial. For that, a 
sensor was included, to read this parameter directly from the outlet of the pump. In order 
to see the data while using the device, there is a small OLED screen attached to it, that 
shows the reading of the pressure sensor. In addition, an incandescent light bulb was 
introduced, which produces heat. This functionality aids in the formation of the blister. 
The block diagram in Figure 9 represents in a simple manner the main components and 
functions of the device.  
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Figure 9: Block diagram of the device’s functioning. Only the main components are represented: the 
vacuum pump to generate the blister, and the microcontroller that receives the data form the sensor and 
shows it in the screen. 
 
The device was modified to have the following elements: Arduino-compatible 
microcontroller, vacuum pump, pressure sensor, pushbutton, resistors, OLED display, 
incandescent light bulb, transistors, capacitor and diode. 
A brief explanation of the basic functions of every component used to build the device is 
offered in the following subsections.  
a) Arduino-Compatible Microcontroller 
Arduino is a platform that allows the development of a broad range of electronic projects 
based on an open-source software and hardware modules or boards [30]. It is a 
microcontroller that, through a programming language, allows for communication 
between the computer and the environment. Said language is composed of a set of 
functions in C/C++ that pass through a compiler (avr-g++) to be translated into machine 
readable instructions.  
For this project a board compatible with Arduino Nano V3.0 was used (Figure 10), with 
the CH340G USB chip instead of the official from Arduino. The programming is done 
through the official Arduino IDE. The main component is an 8-bit microcontroller 
ATmega328P, built by Atmel®, that is based on the AVR® architecture [31]. Because of 
the open-source nature of the Arduino hardware, and software, this device is fully 
compatible with and almost identical to an official Nano. 
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Figure 10 Arduino Nano-compatible V3.0 
board. (a): front, ATmega328P compiler.  
(b): back, unofficial CH340P USB chip (up) 
and ASM 1117 5V regulator (down). 
 
The boards contain a set of analog and digital pins that connect the circuit to the 
microcontroller. In addition, the microcontroller can communicate with the computer 
through a Mini-B USB connector, so that it can be programmed. In this way, it is possible 
to attach different types of electronic components to develop a multitude of projects. 
In order to transform the input voltage to the 5 V that the device operates on, it has a 
voltage regulator (Figure 10 b). In the compatible board used it is the ASM 1117.  
The technical specifications of this board are listed in Table 1. 
 
Table 1: Technical Specifications of Arduino-compatible microcontroller. 
Technical Specifications 
Microcontroller ATmega328P 
Operating Voltage 5 V 
Input Voltage 7-12 V 
Clock Speed 16 MHz 
Analog IN Pins 8 
Digital I/O Pins 14 (6 of which are PWM) 
DC current per I/O pins 40 mA (I/O pins) 
Flash Memory 
32 KB of which 2 KB used by 
bootloader 
SRAM 1 KB 
(a) (b) 
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EEPROM 1 KB 
PCB Size 18 x 45 mm 
Power Consumption 19 mA 
 
The main advantage of this type of microcontroller is that both the software and hardware 
are user friendly but have the option of extension for more advanced users. The addition 
of functionalities in the software is done through collections of code, called libraries. 
Although the code is combined with the basic built-in libraries, it is possible to include 
other more or less complex, that can be official or third-party. The board is relatively 
inexpensive for the great quality and functionalities it provides. 
b) Vacuum Pump 
The vacuum pump is composed mainly of a sealed rigid chamber, an inlet, and outlet 
and a rotary shaft. When it is connected to a DC power source, the current creates a 
magnetic force that moves the shaft, displacing air molecules from the inlet to the 
chamber creating a partial vacuum inside. Air will then enter the pump to replace that 
vacuum, creating a negative pressure. The stages of vacuum generation in a typical 
rotary vane pump are shown in Figure 11. 
 
Figure 11: Typical operation stages in a rotary 
vane pump. 1. Induction of gas into chamber. 
Pressure increases inside as a result if volume rise. 
2. Isolation of gas inside the chamber. 3.  
Compression of gas due to reduction of space. 
4.Exhausution. [32] 
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The vacuum pump used in this work was that shown in Figure 12. The maximum vacuum 
(negative pressure) it provides is 250 mmHg (around 33.3 kPa), with 3 mmHg (0.4 kPa) 
of leakage. Its operating conditions range from 6 to 24 Volts and 0.42 to 0.12 Amperes 
respectively. At 12 V, the current draw is 280 mA.  
 
 
Figure 12: Vacuum pump 
LY370CPM. [33] 
 
c) Pressure Sensor MPX 4115A 
It is an integrated silicon pressure sensor, with a piezoresistive transducer (Figure 13). 
These measuring devices are equipped with the sensing element, calibration circuitry 
and an amplifier. These elements are simplified in the schematic in Figure 14.  
 
 
Figure 13: MPX 4115A NXP Integrated 
Pressure Sensor. [34] 
 
Figure 14: Fully Integrated Pressure Sensor 
Schematic. [34] 
 
Because it is an integrated sensor, the output can be directly converted into ADC, without 
the need for an amplifier [35]. It provides an analog output signal proportional to the 
applied pressure that is being measured. The range of measured pressure is from 15 to 
115 kPa, and the output voltage spans within 4.59 V. Moreover, this device has a good 
sensitivity of 46 mV/kPa. These and other characteristics of the sensor are listed in Table 
2, taken from the sensor datasheet [34]. 
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Table 2: Operating Characteristics of the MPX4115A Sensor. Offset (Voff) is the output voltage at the 
minimum rated pressure. Full Scale Output (VFSO) is defined as the output voltage at the maximum or full 
rated pressure. Full Scale Span (VFSS) is the algebraic difference between the output voltage at full and 
minimum rated pressures. Accuracy (error budget) consists of the output deviation of parameters as 
linearity, temperature and pressure hysteresis, temperature span.  
Characteristic Symbol Min Typical Max Unit 
Pressure Range Pop 15 - 115 kPa 
Supply Voltage Vs 4.85 5.1 5.35 Vdc 
Supply Current Io - 7.0 10 mAdc 
Minimum Pressure Offset Voff 0.135 0.204 0.273 Vdc 
Full Scale Output VFSO 4.725 4.794 4.863 Vdc 
Full Scale Span VFSS 4.521 4.59 4.659 Vdc 
Accuracy - - - ±1.5 %VFSS 
Sensitivity V/P - 46 - mV/kPa 
Response Time tR - 1.0 - ms 
Offset Stability - - ±0.5 - %VFSS 
Maximum Pressure PMAX - - 400 kPa 
Storage and Operating Temperature Tstg, TA -40 - +125 ºC 
 
The value acquired from the analog reading of the sensor is transformed by the 
microcontroller into pressure. This is done using the transfer function (Figure 16) given 
in the datasheet [34], according to the Output versus Absolute Pressure graph shown in 
Figure 15. The final error in the pressure measurement is ±1.5, according to the data 
from Table 2: Operating Characteristics of the MPX4115A Sensor.  
 
 
Figure 15: Output vs Absolute Pressure 
of MPX4115A sensor. [34] 
 
Figure 16: Transfer function of MPX4115A 
sensor. [34] 
 
1. INTRODUCTION 
 
22 
 
d) Pushbutton 
A pushbutton is an electronic component that connects two points in a circuit when 
pressed [36]. The push button chosen was a standard one, with 4 pins.  
e) Resistors 
These components are placed in the circuit to cut or limit the flow of current, to create 
voltage reduction. To do so, they absorb energy, which is dissipated as heat. They are 
composed of a conductor material with a certain resistance measured in ohms (Ω). 
Resistors can play different roles in a circuit, for example, provide voltage control to 
transistors, protect components from excessive current, or act as pullup/pulldown 
resistors [37]. Moreover, another type are the variable resistors, also known as 
potentiometers, that can be set to deliver a certain fraction of the input voltage. 
f) OLED Display  
Monochrome OLED display with 128x64 pixels and 0.96 inches (Figure 17). The screen 
uses a SSD 1306 chip [38] that controls every pixel individually [39]. In addition, it is 
equipped with an I2C interface that makes it very simple to control. This is a serial protocol 
interface that allows to connect to low-speed devices like microcontrollers and other 
systems. It is a simple mechanism that only needs two wires, Serial Data (SDA) and 
Serial Clock (SCL), with pullup resistors to connect any device equipped with I2C [40]. 
Hence, the screen can be easily programmed with the Arduino IDE to display any data 
necessary.  
 
Figure 17: 0.96-inch I2C OLED 
display. az-delivery.de 
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g) Incandescent Light bulb 
It is an incandescent lamp, composed of a filament that emits light and heat when electric 
current passes through it. The filament is inside a sealed bulb filled with an inert gas or 
under vacuum, to prevent its oxidation [36]. The light bulb used for this project is shown 
in Figure 18. 
 
Figure 18: Hella SWS light bulb. 
Technical specifications: 12 V and 5 W. 
 
h) Transistors 
A transistor is an electronic component made from semiconductor materials that has 
three connections (Emitter, Base, Collector). There are two basic types of transistors, 
Bipolar Junction Transistor (BJT) and Field-Effect Transistor (FET). In this project, BJTs 
are used. They are called “bipolar” because both holes and electrons act as current 
carriers. These devices can have two configurations, npn or pnp, which are illustrated in 
Figure 19 which operate similarly, except some features are reversed (polarity, current 
direction and functions of holes and electrons) [41].  
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Figure 19: Bipolar Junction Transistor. Two configurations shown: (a) npn, (b) pnp. Both operate 
similarly, except some features are reversed (polarity, current directions and functions of holes 
and electrons). [41] 
 
BJTs can be seen as a current input (through the base pin) and a current source (from 
the collector) to a circuit, dependent on said input. These devices have two different 
effects on electrical signals: amplification or switch operation. In the present work, both 
transistors have been used as switches, so this process will be further discussed. In 
switch mode, the transistor mainly shifts between two states, saturation and cutoff. In 
saturation, the current through the collector is maximum and does not depend on the 
base; and in cutoff mode, the transistor does not conduct between the collector and the 
emitter. For this purpose, a small current, such as those provided by the microcontroller 
pins, is enough to activate the switch function.  
i) Capacitor 
Capacitors are small electronic components that accumulate charge when connected to 
a power source and deliver it when disconnected. They are composed of two plates, one 
of them accumulates electrons when connected to the DC source, while repelling them 
in the other. As the power is cut off, the electrons migrate, creating a temporal current 
source [37]. The charging and discharging behavior of these components is exemplified 
in Figure 20. 
 
Figure 20: Capacitor charge and discharge 
behavior [42]. 
 
(a) (b) 
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j) Diode 
Diodes have two terminals, an anode and a cathode, and only allow current in one 
direction, when forward biased. This happens when the anode has a positive voltage 
that is higher than on the other end [37]. The applications may vary, and in this project, 
it is used to block the current from flowing in a certain way. 
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Suction-induced blisters have been studied as a useful tool to evaluate dermo-epidermal 
junction integrity. An early report from 1875 has been found where blisters where induced 
by cupping [43]. In the following years, other studies were developed [44]–[46] where 
cupping and direct vacuum were applied to the skin to observe skin separation with 
further histological assays. In addition, another skin split method has been reported that 
consists on separation by a sodium chloride solution [47].  
Nowadays, suction split is used in research to generate standardized wound healing 
models, epidermal grafting, and other phenomena in the skin.  
According to recent studies on blistering time on healthy skin patients [48], dermo 
epidermal adherence is influenced mostly, by skin temperature, and negative pressure 
plays a secondary role. Higher temperatures have been observed to decrease blistering 
time, as molecular processes leading to detachment or inflow of blister fluid seem to be 
enhanced. All in all, suction blistering time has been proven to be an indicator of DEJ 
adherence, as it provides information about the structural integrity of deeper 
subcutaneous layers. 
A study from 1984 reported suction blister times measured for different types of EB in 16 
patients with EBS [49]. The suction was applied with a suction cup connected to a 
vacuum pump delivering 200 mmHg (26.5 kPa) of negative pressure in different parts of 
the body (abdomen, arm, thigh and lower leg, corresponding to sites of predominant 
blistering). Temperature at blister site was measured after completion. The phenotypes 
included were: JEB (severe and non-lethal), dominant DEB (mild, moderate and severe) 
and RDEB (mild and severe). The results showed that mean blister times for all patients 
were around 80 minutes except for JEB subjects on whom the time for blister appearance 
was 10 minutes.  
A different report compared salt split skin to suction split as a routinary method for 
differential diagnosis of two mechanobullous diseases [50]. The vacuum pump seen in 
Figure 21 was used to generate blisters at 300-350 mmHg (approximately 40-46 kPa) 
for 45 to 60 minutes in both normal and diseased skin. Biopsies were taken, as well as 
others for salt splitting, and analyzed by immunofluorescence. The results showed the 
presence of hemidesmosome proteins at the top of the blister, and basement membrane 
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components (collagens IV and VII, laminin) at the bottom. In addition, suction split was 
determined to be a more accurate, easier and faster diagnostic tool than salt split.  
 
 
Figure 21: Suction split apparatus. Hand vacuum 
composed of a plexiglass plate, with a terminal 
hole of 3 mm, and a pressure gauge, attached to 
perilesional areas. [50] 
 
In a clinical study for Potential of Systemic Allogeneic Mesenchymal Stromal Cell (MSC) 
Therapy for Children with Recessive Dystrophic Epidermolysis Bullosa [51]. Suction 
blisters were induced and times measured before and after MSC infusion using a 
negative pressure device (Electronic Diversities, MD, USA). The device is composed of 
a negative pressure source, connected to a suction chamber attached to the patient’s 
skin. Inside the chamber, two light bulbs provide heat to the area. The pressure was set 
to 12–15 mmHg that produced a suction blister in a healthy person in 60 minutes. The 
mean blister times for the RDEB patients were of 10 minutes before any treatment (and 
reduced by 2 minutes after MSC infusion). 
The most recent application of this method is currently being developed by researchers 
from Stanford University. Skin adherence for Recessive Dystrophic Epidermolysis 
bullosa (RDEB) patients is being measured [52]. The setup includes a suction blister 
device in a contact plate complemented with a heating ring and LEDs to illuminate target 
skin, connected to the corresponding power sources and to a laptop with a live imaging 
program. Reported results show that, at controlled conditions of negative 685 ± 30 mmHg 
(91 ± 4 kPa) and 37 ± 1 ºC, for healthy subjects 29.7 minutes are needed to generate a 
1 mm wide blister, whereas for RDEB only 5.7 minutes were necessary. In conclusion, 
the device built is a useful tool to measure skin adherence at the DEJ, in a robust and 
quick way that can be implemented in clinical trials.  
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The main procedures performed in this work were the fabrication of the suction device, 
and the in vivo experiment with the corresponding tissue analysis.  
3.1. Device Assembly 
In the previous section the device characteristics were explained, along with an overview 
of the functions of every component used in its fabrication.  
The apparatus used as a model to build the actual suction device was composed of a 
vacuum pump, a button which changed through three intensities, and a connector to 
charge a battery inside it (Figure 8). The only components conserved were the pump 
and the mini USB connector. 
The first step was to include the Arduino-compatible microcontroller. It is powered 
through the pin Vin with 12 V. As it is designated in the technical specifications of Table 
1, the microcontroller works with 5 V, but the Vin pin was connected to the ASM 1117 
voltage regulator which allows a maximum of 12 V input. The ground was connected to 
the voltage source.  
The second most important component added was the vacuum pump (Figure 12). Its 
positive end was attached to the 12 V power source, in order to obtain maximum force. 
The negative end was connected to the collector of a npn transistor, a simple model 
TIP41. With the emitter of the transistor linked to ground, and the base to the 
microcontroller, it acts as a switch. From the D5 pin of the Arduino-compatible board the 
signal is sent so that the motor turns on with a certain intensity. This signal is a PWM 
(Pulse-Width Modulation), that works by modulating the duty cycle –“on time” or average 
between pulses– of a signal received [53], in this case from the potentiometer. The 
vacuum pump will receive a power supply equivalent to the mean of the time that the 
potentiometer has been at 0 and 5 V. In this way, it is possible to provide a continuous 
energy supply from two discrete signals. The potentiometer values are those form an 
analog signal transformed into 8-bit digital (discrete) values at the microcontroller analog 
pin (0-1023 range resolution). Through Equation 1: PWM transformation formula, the 
value from the potentiometer is converted into a pulse-width modulation signal to be sent 
to the motor. This equation is introduced to adjust the working range of the pump. Before, 
the potentiometer value span did not match the motor’s. This meant that the minimum 
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energy to overcome mechanical resistance and inertia of the motor’s shaft was far higher 
than the minimum signal sent by the potentiometer. The PWM formula was introduced 
to adjust the signal sent to the motor to be able to use the whole value scope of the 
variable resistor.  
 
Equation 1: PWM transformation formula. 
𝑷𝑾𝑴 =  (𝒑𝒐𝒕𝒆𝒏𝒕𝒊𝒐𝒎𝒆𝒕𝒆𝒓 𝑨𝑫𝑪 ∗ 𝟎. 𝟐𝟏) + 𝟒𝟎 
 
Therefore, the output is controlled, between 0 and 5 V, so that the transistor is able to 
undertake it. In addition, a 220 Ω resistor was included in the base to protect the 
transistor from excessive current. The intensity of the signal sent to the motor is 
controlled by a potentiometer, powered by 5 V, and linked to the A1 microcontroller pin.  
The element that turns on and off the device is a simple standard pushbutton, with one 
end to the microcontroller 5 V provider pin, and the other to the D2 pin for reading the 
state of the pushbutton through the microcontroller. As the intention was to keep the on 
directive without having to continuously press the button, a pulldown resistor (220 Ω) 
was included between it and the ground. Therefore, when it is pressed once, the Arduino-
compatible device receives the new state of the button, and initializes the whole device 
(including motor, light bulb, and pressure sensor). When pressed again, it stops.  
Another essential component introduced was the pressure sensor MPX 4115A (Figure 
13). It is supplied by 5 V, and the reading from it is delivered to the microcontroller to be 
transformed into pressure values through the analog pin A0. The sensor is connected 
directly to the pipe from where the pump draws air from the outside through a small fork-
like part. One side was connected to the motor outlet, the other to the measurement 
component, and the last one to the device’s outlet. Therefore, the measurements of the 
pressure in the outlet of the device (contact with the skin) can be taken as accurate, 
considering the error of the sensor (Table 2).  
To complete the functionality of the device, a small 12 V light bulb was introduced. 
Controlled again by a transistor (BC547) acting as a switch –with a 220 Ω resistor to 
protect the base–, it was installed so that it turns on and off with the other components 
to a medium intensity (150 out of the digital scale of 0-255). Another resistor was added 
to protect the light bulb from excessive current.  
Finally, the device fabrication was completed with the addition of the small OLED screen 
(Figure 17). As it was described in the previous section, the screen is equipped with an 
I2C module, and it was connected to the board through the designated pins for this 
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purpose: pin A4 for SDA and A5 for SCL. The pullup resistors needed for these 
connections are provided by the microcontroller internally, which turn on automatically 
when the I2C protocol is initialized [40]. To power it, it was linked to the 5 V and ground 
pins. Although the OLED display was designed for operating at 3 V, it is tolerant to 5 V, 
so it could be connected directly to the microcontroller board [39].  
The device’s circuit schematics were represented using the tool Eagle and can be seen 
in Figure 22. 
 
 
Figure 22: Schematics of the circuit. In the middle, the Arduino-compatible microcontroller, along with a 
capacitor (C1) and a potentiometer (R5). On the right side of the figure, the OLED screen and the 
pressure sensor (PS1). On the left, the pushbutton (SW1), light bulb (LMP1) and vacuum pump (M). As 
well as these key elements, other components such as resistors (R1-4), transistors (T1-2) and a diode 
(D1) are introduced for optimization purposes. 
 
Regarding the power supply, the machine needs a 12 V for the vacuum pump, the 
Arduino-compatible board and the other components, which are provided by an external 
transformer (Salcar Electronics) through a mini USB connection to Vin. This pin in the 
microcontroller stands up to 12 V, according to the technical specifications in Table 1. 
The motor and light bulb draw power directly from this voltage source, as they need 12 
V to function, and the other components are provided by the 5 V pin in the board. As for 
the current consumption, a raw estimate of the maximum needed was calculated in order 
to select the power source’s characteristics. The microcontroller draws 24 mA when 
being powered by 12 V, and it can provide up to 200 mA through its pins. The vacuum 
pump consumes a maximum of 280 mA at 12 V. The pressure sensor consumes 10 mA, 
the OLED screen 20 mA, and the light bulb consumes 416 mA. This makes a total of 950 
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mA. Considering the other less consuming components, and to be safe, the current 
source chosen was of 3 A.  
3.2. In vivo Model of Human Skin with Epidermolysis Bullosa 
For this work, skin grafts using human plasma as a dermal scaffold were generated. To 
do so, fibroblast and keratinocyte primary cells were cultured. Then, artificial skin grafts 
were constructed following the specific protocol. Two models were generated, healthy 
(control), and diseased with both cell types taken form a patient with Recessive 
Dystrophic Epidermolysis bullosa (RDEB), carrying the c.6527inC mutation in COL7A1 
gene [54], [55]. 
3.2.1. Cell Culture 
Primary dermal RDEB fibroblasts and healthy cells were cultured in treated 75 ml 
ventilated flasks (F75) with Dulbecco’s Modified Eagle Minimum Essential Medium 
(DMEM 1X) supplemented with 10 % Fetal Bovine Serum (FBS) and 1 % antibiotic to 
inhibit growth of contaminants. They were cultured in at 37 ºC in 95 % humidity and 5 % 
CO2 conditions (Shel Lab C02 Serie; Sheldon Mfg. Inc incubator). Culture medium was 
replaced every 2 days with fresh media with the aid of the phenol red indicator [56]. 
Whenever confluence was reached, passages to subcultures were done to ensure 
proliferation and avoid senescence. The detachment of cells was done by trypsinization. 
After removing the medium, the cells were incubated with trypsin. The trypsin was then 
neutralized with medium, to avoid cytotoxic effects, and the sample was centrifuged for 
7 minutes at 1000 rpm. Finally, the pellet was resuspended, and the cells seeded in the 
flask.  
Primary human keratinocytes were obtained from skin biopsies of healthy and RDEB 
donors by enzymatic digestion according to previously described methods [57]. Donors 
provided informed consent for biopsy. Permission was obtained for specimens taken 
from organ donors. Primary keratinocytes were cultivated with a feeder layer in a culture 
medium. The feeder layer was composed of fibroblasts of the cell line 3T3 J2, obtained 
from embryonic mice tissue, needed to initiate keratinocyte colony formation [57]. The 
cells were seeded with DMEM and 10 % Newborn Serum (NB). After that they were 
irradiated (50 Gy) and seeded again in a F75 (approximately 2 million cells for the whole 
surface). Pre-confluent or newly confluent first-passage primary human keratinocytes 
were trypsinized and seeded at a density of 1 x 105 cells per 100-mm dish onto the feeder 
layer. After 3 days of culture, keratinocytes were transduced by incubation with a 
recombinant EGFP-expressing LZR-based lentivirus generated by transient transfection 
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in 293T cells, as described [58]. After two infections, the cells were given fresh medium 
and allowed to reach 80-90 % confluence. Keratinocytes were then trypsin detached, 
analyzed for EGFP expression and sorted. 
All cellular cultures were always manipulated inside biosecurity cabins (Telstar, Bio 
IIA/G) and cryopreserved when needed at -83 ºC in a freezer (Unicryo DW-86L286) using 
freezing medium Dimethyl Sulfoxide 10 % (DMSO, Sigma Aldrich) in FBS.  
3.2.2. Plasma-based Artificial Skin Construction 
The basis of the skin models is to generate a functional dermal component that interacts 
dynamically with the keratinocytes during in vitro maturation as well as in vivo after graft 
transplantation. To do so, fibrin gels are created from fresh frozen human plasma, taking 
advantage of the human endogenous fibrinogen coagulation process aided by calcium 
cations (Ca++). 
The fresh plasma was obtained by the primary separation of blood of donors from the 
blood bank of Asturias (Centro Comunitario de Transfusiones del Principado de 
Asturias), following the rules and recommendations of American Association of Blood 
Banks [59]. Plasma-based dermal grafts were prepared in 6-well plates (Costar, 
Corning). For each fibrin gel 3 ml of final product were prepared. First, 4000 cultured 
fibroblasts were added (1000 per cm2) to 1.5 ml of a saline solution (NaCl). Cells were 
counted in a Neubauer chamber, and their viability was assessed with Trypan Blue 
solution [60]. Then, 24 μl of tranexamic acid (Amchafibrin, Fides Ecofarm, Barcelona, 
Spain) were added to inhibit fibrinolytic activity from the fibroblasts. Finally, 1.75 ml of 
fresh human plasma (2.44 mg/ml of fibrinogen) were added, along with a CaCl2 solution 
to induce fibrin coagulation. The mixture was placed on the plates. Solidification was 
complete after 2 hours of incubation at 37 ºC, and culture medium was added. One day 
after 1.5 million of purified EGFP+ healthy, RDEB were seeded on the corresponding 
fibrin matrices to form the epidermal layer of the artificial skin. The complex was cultured 
until keratinocytes confluence was reached.  
3.2.3. In vivo Regeneration of Artificial Human Skin 
Genetically engineered skin constructs were manually detached from the plate and 
placed orthotopically on the backs of immunocompetent mice. Four mice were grafted 
(two healthy, two with RDEB). Briefly, mice were aseptically cleansed. Full-thickness 12 
mm circular wounds were then created on the dorsum of mice to match skin equivalents 
as seen in Figure 23 A. Mouse skin removed to generate the wound was devitalized by 
three repeated cycles of freezing and thawing and used as a biological bandage, fixed 
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with sutures, and covered to protect and hold the skin substitute in place during the take 
process (Figure 23 B-H). Dead mouse skin was expelled, generally within 15 days of 
grafting, and regenerated human skin became visible Figure 23 I, J. Grafting was 
performed under sterile conditions, using 6-week-old female NUDE mice purchased from 
the Janvier Laboratory and housed under pathogen-free conditions for the duration of 
the experiment at the Centro de Investigaciones Energéticas Medioambientales y 
Tecnológicas (CIEMAT), Laboratory Animals Facility. Animals were housed in 
individually ventilated type II cages, with 25 air changes per hour and g-irradiated (10-
kGy) soft wood pellets as bedding.  
 
 
Figure 23: Transplant procedure of human skin equivalents. A) Mouse skin removal. B), 
C) Freezing and thawing (respectively) cycles for mouse skin devitalization. D) Skin 
equivalents prepared for transplant. E), F) Implantation. G), H) Stitching of previously 
devitalized skin on top of the implanted skin to make a biodegradable and biocompatible 
bandage. I), J) Human skin regeneration in mice. [61] 
The transplant was analyzed under fluorescent light microscopy to observe its maturation 
stage. After 8 weeks, it was successfully integrated, and mice could be taken to perform 
the in vivo device experiment.  
3.3. In Vivo Testing: Blister by Suction 
Mice were observed under fluorescence to determine the section of human skin that was 
present. Green fluorescence was readily visualized in the intact xenograft in vivo (Figure 
24), using a fluorescence stereomicroscope under blue light (Olympus America, Melville, 
NY). Before applying any suction, the incandescent light bulb was set on top of the area 
3. METHODS AND MATERIALS 
 
34 
 
to be examined, approximately 2 cm away, for 2 minutes. The heat received at such 
distance in the skin was calculated approximately to be 35 ± 5 ºC. After that, the bulb 
was kept on for the entire duration of the experiments to maintain the heat.  
 
 
Figure 24: Green fluorescence in xenograft 
in vivo. 
 
Figure shows examples of how the suction device was employed in the different 
experiments. An initial trial was performed to obtain an idea of how much time and 
pressure was needed to generate the blister. With a big outlet (9 mm), that span the 
small section of human tissue as well as that of the animal, suction was applied to a 
delimited area of the skin as seen in Figure 25 b. After that, the outlet was changed to a 
smaller cross section (3 mm) to increase pressure force on the skin, considering 
pressure as 𝑃 =
𝐹
𝑆
.  
Three experiments were completed on another mouse with regenerated RDEB human 
skin. In this model the human skin surface taken by the mouse span a big area, which 
made it possible to do three separate tests. The previous assessment was taken into 
consideration to choose the conditions applied. First, the device was set to maximum 
pressure for 7 minutes. For the second and third tests, the pressure was lowered to 80-
85 kPa and applied during 7 and 5 minutes respectively. Moreover, two control models 
were tested for 5 minutes at 65-70 kPa and 80-85 kPa. Examples of the process can be 
seen in Figure 25 c-f, including the control model. 
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Figure 25: In vivo experiments on the regenerated human plasma-based skin 
grafts. (a) Overview of the device being applied to the mice model using the small 
outlet (3mm). (b) Initial assessment with 9 mm outlet. (c) Initial assessment with 
the smaller 3 mm outlet at maximum pressure for minutes. (d) Test on control 
model for the same conditions (C1). (e), (f) Second and third experiments (E2, 
E3), with the 3 mm outlet. (g) Biopsy of the human skin graft (delimited in black) 
with a margin of approximately 2 mm of surrounding mouse skin.  
 
(b) 
(g) 
(d) 
(c) 
(e) 
(f) 
(a) 
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To complement this work, the device was tested on a mouse with a skin graft corrected 
to produce C7. This was provided by a laboratory group within CIEMAT, which had 
produced genetically edited human skin mice models using CRISPR/Cas9 complex. A 
mutation in exon 80 of COL7A1 gene (c.6527insC) was the target for the gene editing 
approach. CRISPR/Cas9 pairs flanking exon 80 were delivered to primary patient 
keratinocytes by electroporation. Keratinocytes used were obtained from the same 
patient that provided the cells for this present work. Gene correction was done by NJHR. 
Skin equivalents were generated with polyclonal keratinocyte cultures in which COL7A1 
reading frame had been restored and C7 was being expressed. Normal human skin was 
developed upon transplant onto immunodeficient mice. These grafts showed C7 
deposition at the basement membrane zone, formation of anchoring fibrils and structural 
integrity when analyzed ten weeks after grafting. This proved that epidermal stem cells, 
able to sustain long-term skin regeneration, had been successfully corrected. 
The last conditions tested (5 minutes at 80-85 kPa) were applied to half of the grafted 
human skin, the other half taken as control sample.   
The experiments are summarized in Table 3. 
 
Table 3: Summary of suction skin splits, combinations of skin type, time and pressure applied. 
 Skin type Time (min) Negative pressure (kPa) 
Control 1 (C1) Healthy 5 65-70 
Control 2 (C2) Healthy 5 80-85 
Experiment 1 (E1) RDEB 7 65-70 
Experiment 2 (E2) RDEB 7 80-85 
Experiment 3 (E3) RDEB 5 80-85 
 
The regenerated human skin grafts were excised after 5 minutes (to allow the blister to 
settle) along with approximately 2 mm of surrounding mouse skin (Figure 25 g). To 
maintain the tissue in a reliable state compared to the living one, the excised samples 
were placed in 10% buffered formalin for paraffin embedding for further analysis.  
3.4. Analysis of Regenerated Artificial Human Skin Split by Suction 
The tissue biopsies taken were fixed in 10% formalin. For paraffin embedding, the tissue 
was treated with a series of graded ethanol solutions (VWR Chemicals Prolabo) to 
dehydrate it. Moreover, to remove the still non-miscible (in paraffin) alcohol, remaining 
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fat, and increase transparency, the samples were introduced in xylene (Scharlab S.L.). 
Tissues were carefully placed in melted wax at 58 ºC for 15 minutes and solidified by 
freezing. A microtome (Leica RM2255) was used for cutting the sample into 5 µm slices. 
The slices were rapidly set in water at 40 ºC to smooth them out and placed in glass 
slides (Super Frost Ultra Plus, Thermo Scientific). Before histological and 
immunohistochemical studies, the samples were deparaffinated with sequenced 
reduced ethanol concentrations and xylene. 
3.4.1. Histological Analysis: Hematoxylin and Eosin Studies 
Samples were stained following the standard procedure. First, the tissue was rehydrated 
in three consecutive alcohol solutions (100 %, 95 % and 70 %). Then, samples were 
introduced in hematoxylin stain for 5 minutes and washed to remove the excess with HCl 
1 %. After that, the slides were placed in Bluing reagent for 1 minute. Then, they were 
washed in running tap water and rinsed in 95 % alcohol before they were counterstained 
with eosin for 5 minutes. After rinsing the excess stain, samples were dehydrated in 
consecutive alcohol solutions (70 %, 95 % and 100 %) and cleared in xylene. Finally, the 
samples were mounted and visualized under the microscope to determine if blisters were 
present. Six slides of each tissue were selected, where most prominent blister was seen, 
to perform the corresponding immunohistochemical studies. 
3.4.2. Histological Analysis: Immunohistochemistry Studies 
In experimental grafting protocols, formalin or ethanol fixed sections were stained using 
specific antibodies against human collagen VII (Col7 LH 7.2, provided by Dr. Nyström, 
University of Freiburg, Germany), anti-human cytokeratin 10 (monoclonal AE2, ICN 
Biomedicals, Cleveland, OH), anti-human cytokeratin 14 (clone LL001 Santa Cruz, USA) 
and anti-human vimentin (V9, BioGenex, San Ramon, CA). The last antibody was 
applied to ensure the presence of fibroblast in the dermis.  
An immunoperoxidase analysis was done to detect collagen VII in the selected samples. 
Proteinase k (DAKO Agilent S-3004) was dissolved in Tris-HCl 50 mM for antigen 
retrieval during 10 minutes at room temperature. After washing with PBS 1X, the tissue 
samples were incubated for 30 minutes with a solution of 0.1 % Triton (Merck) and 3 % 
H2O2 in PBS to inactivate endogenous peroxidase activity. Then, they were washed 
again, and the unspecific binding was blocked by incubating in 3 % Bovine Serum 
Albumin (BSA, Merck) in PBS for 30 minutes at room temperature. The primary antibody 
Col7 was left to react overnight at 4 ºC. The next day, the secondary antibody was 
incubated for 45 minutes. Then, the secondary antibody detection was done with the 
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avidin-biotin complex (ABC, Vesctastain) kit, which was placed on the samples and left 
in the dark for 40 minutes. Finally, after removing excess with PBS, the tissue samples 
were developed with DAB (3, 3 -diaminobenzidine) HRP substrate (Vector). DAB is 
oxidized when reacting to hydrogen peroxide, which is present in the peroxidase enzyme 
conjugated with the antibody, thus producing a brown precipitate. The intensity of the 
color was controlled under optical microscope and stopped by non-distilled water when 
appropriate.  
For vimentin, cytokeratin 10 and cytokeratin 14 immunohistochemical analyses, the 
antigen retrieval was heat mediated. The samples were placed in a 2 % citric acid and 8 
% sodium citrate solution and heated at 300 W up to boiling of reagent. The endogenous 
peroxidase was blocked then with a 0.3 % H2O2 in methanol solution for 10 minutes. The 
sample was blocked with 3 % BSA/PBS for 45 minutes, and the respective primary 
antibodies were placed overnight on each tissue sample. The following steps were the 
same as described for the collagen VII assay.  
All samples were counterstained with hematoxylin to guarantee nuclei observation, 
dehydrated and cleared as previously explained, and mounted with the Shandon Xylene 
Substitute Mountant machine (Thermo Scientific). 
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4. RESULTS 
4.1. Suction Device 
When the device was correctly assembled and programmed to perform the desired 
functions, it was examined to verify the basics. The end product can be seen in Figure 
26. To set it up, only three steps must be followed: plug the charger to a regular wall 
socket, connect it to the mini USB inlet at the bottom, and insert the outlet chamber. 
 
 
Figure 26: Finalized device. 
Included in the picture are the 
OLED screen, incandescent 
light bulb, outlet chamber and 
mini USB charger cable. 
 
To assess the behavior of certain components, a computer program was used, 
Telemetry Viewer. By connecting the microcontroller to the computer, it was possible to 
obtain real time measurements of the desired signals sent to and from the digital or 
analog pins. First, it was important to confirm that potentiometer changes modified the 
PWM signal accordingly. In Figure 27 both signals are plotted at the same time, between 
0 and 5 V. It can be seen that the changes in potentiometer values correspond to 
changes in PWM (according to Equation 1), which then modify the power of the motor.  
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Figure 27: Potentiometer and PWM voltage signals sampled 
through time. 
 
Having confirmed that, the functioning of the pressure sensor is assessed. The scaled 
graph from Figure 28 shows the evolution of sensor voltage throughout 1000 samples at 
maximum pressure (lower than 65-70 kPa, as it is supplied by the 5 V provided by the 
USB computer connection and pressure does not reach the maximum measurable by 
the sensor). It is clear that the pressure signal fluctuates over time, but the deviations 
should be neglected as the scale is small, 0.01 V. The change observed corresponds to 
pressing the sensor outlet on the skin, which lowers the pressure as the surface is 
covered and air is not flowing freely.  
 
 
Figure 28: Voltage signal from the pressure sensor. 
 
 
4. RESULTS 
 
41 
 
4.2. Suction Split Skin Analysis 
The skin was left for 5 minutes after application of vacuum to allow blister settlement. 
The pictures in Figure 29 were taken at that moment, before obtaining the biopsies. They 
show a macroscopic overview of the skin grafts after applying suction. The black lines 
limit the area of human skin within the mouse’s back.  
 
   
Figure 29: Macroscopic view of suction-induced blisters before excision. C1: 5 min 65-70 kPa. E1: 7 min 65-
70 kPa. E32: 7 min 80-85 kPa. E3: 5 min 80-85 kPa. 
 
In the first image of Figure 29 the first control model is shown, after suction. In the first 
experiment (E1), the induced wound appears to be smaller, as does the third one (E3). 
In the case of experiment 2 (E2), the blister generated is in a circular shape, being 
approximately the size of the device as well. For E3, the blister area appears to be 
elevated upon first sight, in the conventional way a regular blister would be in healthy 
skin (from a small burnt for example). 
The stained samples were observed under light microscopy and pictures were taken on 
relevant sections of each.  
4.2.1. Microscopic Confirmation: Hematoxylin and Eosin (H&E) Stain and 
Immunohistochemical Studies 
Upon first observation of the samples, the regions of interest within the different 
experiments were selected for further histological analysis. H&E stain was decisive as it 
provides a general view of the tissue structure and components. In this step, the 
C1 
E1 
E2 
E3 
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consequences of each experiments were determined, and the slides of most importance 
were selected for the subsequent analyses.  
In Figure 30 a and b, two images taken from the control samples are shown. The first 
one (a), is of a section where suction was applied (C1, 65-70 kPa for 5 minutes). The 
second, (b), is taken from an area where no forces were induced. No damage is found 
in any of the images, which implies that blistering only occurs in diseased skin (with the 
times tested).  
For the first experiment (E1), with maximum pressure (60-65 kPa) for 7 minutes, the 
dermis appears to be torn and the skin extended upwards, as seen in Figure 30 c, d. The 
dermoepidermal junction appears ripped as well (asterisks in Figure 30 d), but more 
extensive holes are seen in the dermis (circle in Figure 30 d). Figure 30 e shows the 
blister generated in E2. It is considerably big, but dermal breakage can be still observed. 
The third experiment produced a definite blister with minimal dermal disruption (Figure 
30 f). 
As well as the H&E stain, the analysis of vimentin allows for distinguishing the structural 
integrity of the dermis. In Figure 31, control (a) and RDEB (b, c, d) samples are shown 
to compare dermal integrity. Healthy skin conserves proper structure of both epidermal 
and dermal components, while diseased skin in E1 (Figure 31 b) has completely lost it 
after the experiment. In (c) the results from E2 can be observed. Blister appears with 
some minor dermal damage. Finally, (d) is an image taken from E3, where the dermal 
component is almost intact, and no lesions are observed except for the blister at the DEJ.  
To verify that the formation of blisters is caused by absence of collagen VII (C7) in the 
RDEB skin equivalents, immunohistochemistry studies with antibody against human C7 
were done and control and EB samples were compared (Figure 32). C7 appears in a 
brown color along the dermal-epidermal junction, while cell’s nuclei were counterstained 
in blue for better visualization. The blister generated in E3 can be seen in Figure 32 b, 
and it is corroborated that C7 was not present in the tissue sample due to the RDEB 
condition of the cells.  
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Figure 30: Hematoxylin and Eosin stained images. Blisters on the DEJ are pointed out by asterisks and those on the 
dermis are designed by circles. (a) is an image from C1 (10X). (b) is an image of a healthy sample with no pressure 
applied to it (10X). (c) and (d) correspond to images taken of the samples of E1, with 4X and 10X lenses, respectively. 
The pressure and time was excessive, and the dermis torn all over, with intradermal blistering. In (d), the blister formed 
in E2 is shown at a resolution of 10X. (e) presents a 10X image of the blister formed in E3. 
(b) (a) 
(f) (e) 
* * 
* 
º 
(c) 
* 
(d) 
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Figure 31: Vimentin immunostaining. Blisters on the DEJ are pointed out by asterisks and those on the dermis are 
designed by circles. (a) corresponds to the second control sample (10X), where tissue integrity is intact with healthy 
collagen fibers. (b) is an image of E1 (10X), where the dermis is structurally compromised, and intradermal blisters 
are seen. (c) image from E2’s big blister with certain dermal damage and small intradermal blisters (10X). (d) blister 
generated in E3, no intradermal blistering and minimal extension of the dermis (10X). 
 
   
Figure 32: Collagen VII immunostaining. Blisters are pointed out by asterisks. (a) shows the healthy control sample in 
10X resolution and (b) shows the blister formed in experiment 3 without C7 presence (10X). 
º 
º 
* 
* 
(a) (b) 
(c) (d) 
* 
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Stains against specific markers of the epidermis were performed to determine how well 
the skin equivalents were differentiated and developed, and the level of rupture during 
blistering in E3. In all samples (control and RDEB). The two proteins studied were 
situated in the appropriate locations, as seen in Figure 33. Cytokeratin 10 (K10) can be 
observed in the suprabasal layers, up to the stratum corneum; while cytokeratin 14 (K14) 
is only seen in the basal keratinocyte layer. In addition, the images verify that blisters 
were formed at the dermal-epidermal interface, with no keratin appearing below the 
blister (Figure 33 c, d).  
   
   
Figure 33: Cytokeratin 10 and 14 immunostaining. Blisters are pointed out by asterisks. On the top row, 
the control samples are shown, and in the bottom, E3 blister. All pictures were taken at a 10X 
resolution, stained for K10 and K14 and counterstained in blue for nuclei. (a) and (c) are taken from the 
K10 immune assay. Colored areas correspond to this protein’s location in the suprabasal epidermal 
layers. (b) and (d) correspond to the K14 stain. Hence, color is seen in the basal kerainocytes. (b) 
appears to be stained in the dermal layer as well, due to too much time of exposure to developing 
substance. 
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4.2.2. Gene Edited Human RDEB Skin  
The suction device was tested on an animal model provided by a research group within 
CIEMAT where by gene editing, the same mutated skin used in our studies were 
corrected for C7. A negative pressure of 80-85 kPa was applied to the skin for 5 minutes, 
to corroborate that the gene editing procedure was successful. Figure 34 shows the H&E 
stained samples, one where pressure was applied (b) and a control one (a). Figure 35 
shows images of these two samples as well after an immunohistochemical assay for 
collagen VII. It is clear from both sets of images that the gene editing process was 
effective. The tissue structure was conserved before and after suction, and C7 is visible 
correctly in the DEJ as shown in Figure 35. No dermal damage or blisters were found.  
 
   
Figure 34: Hematoxylin and Eosin stained images of COL7A1 corrected skin equivalent. (a) is taken from 
the control sample (10X), where no pressure was applied, and (b) is from the area where 80-85 kPa were 
applied for 5 minutes (10X). 
 
   
Figure 35: Collagen VII immunostaining of samples of COL7A1 corrected skin equivalent. (a) is taken from 
the control sample (10X), where no pressure was applied, and (b) is from the area where 80-85 kPa were 
applied for 5 minutes (10X). 
    
(a) (b) 
(a) (b) 
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5. DISCUSSION 
In the present study, the generation of blister wounds in Recessive Dystrophic 
Epidermolysis Bullosa was studied. It has been established [48] that blistering time is an 
indicator of dermoepidermal adherence, which leads to diagnosis of skin disorders such 
as Epidermolysis bullosa. Previous reports have been found where suction has been 
used as a method for generating blisters for diagnostic purposes in EB and other 
genodermatoses [44], [45], [49]-[51]. Based on the relationship between blistering time 
and DEJ adherence, which can be correlated to a specific skin disorder, a standardized 
methodology must be generated and applied so that a unified diagnostic criterion exists 
in such cases. This is extremely important in rare diseases, which often have few 
treatment options available, and early diagnosis can speed the access to it. In addition, 
the more patients are identified to have such diseases, the more research advances are 
made in their field. This work focused on determining the optimal blistering time for 
RDEB, a severe type of the rare disease Epidermolysis bullosa.  
To do so, a suction device was developed to fit the desired characteristics. The key 
parameters to be considered were negative pressure and time, with the temperature of 
the tissue influencing the events. To have distinct and real-time data of these variables, 
a sensor was introduced, as well as a small screen to see the values without having the 
device continuously connected to a computer. This would have defeated one of the main 
objectives of the project, having a manageable tool for comfortable use in future every 
day clinical diagnostics. A timer was established in the microcontroller to determine how 
long the suction was applied for. A core component is the Arduino-compatible board. It 
proved to be a simple and easy to use microcontroller, providing every function that was 
needed with option for personalization due to its open-access software [30]. Basic 
electronic components such as resistors and a diode were introduced along the process 
to avoid excessive current and damage. After trying out the finalized product, it was clear 
that the choices were correctly made. The device is easy to set up, only needing to insert 
the outlet chamber, plug the charger into the micro USB connector, and check if the 
screen is correctly connected. All elements are shown in Figure 26. It was important to 
achieve this, as the precedents for this project are bulky, multi-piece devices 
uncomfortable for the patients and clinicians [50], [52].  
RDEB human skin equivalent mice models were generated for testing the device and 
determining the correct parameters through histological analysis. Healthy models were 
created as well for reference purposes. The method employed was described in previous 
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works [29]. A dermal component was generated by employing a mechanism present in 
wound healing, fibrin clotting. A scaffold for fibroblasts to be embedded on was created 
that way, which also served as support for the epidermal component (keratinocytes). 
Amongst the advantages of this bioengineering method, the possibility of building a 
completely autologous skin graft is one of the most important. The three main 
components can be obtained from the patient. In cases such as EB, where the cells are 
at fault for the disease, gene editing methods could be introduced to complement and 
complete the therapy [18], [22], [24].  
Skin regeneration on the animal models was done by qualified scientists, and after two 
months they were completely differentiated and available for testing. In healthy skin 
equivalents, tissue architecture was developed properly, with accurate dermal structure 
and epidermal differentiation (Figure 30 a, b). For the RDEB models, tissue was properly 
formed as well, without collagen VII due to the condition of the cells within the tissue, as 
seen in Figure 32 b. For both types, the histology images give a good impression of the 
constitution of the skin grafts. The dermis had the proper configuration as evidenced in 
the vimentin examination (Figure 31 a, control sample). In all cases (healthy and 
diseased) the epidermal component presented no damage in any of its layers, as 
evidenced in the cytokeratin immune assays in Figure 33. Cytokeratin 10 and 14 were 
observed in the corresponding epidermal layers (suprabasal and basal keratinocytes, 
respectively). None of these proteins must be compromised in RDEB grafts, as it only 
affects collagen VII in the DEJ [55].  
Regarding the blister generation on the actual human skin models, the analysis of the 
results provided a combination of time and pressure to create a proper blister. First, it is 
necessary to define what a «proper blister» is. Taking into account that this work is 
dealing with RDEB, a good resulting blister would be one that separates the dermal and 
epidermal components, without any of them ending up torn or damaged.  
In experiment 1 (E1), the maximum pressure was applied (65-70 kPa) for 7 minutes. By 
exerting the same force during a longer and continuous time period, the errors found in 
the previous experiment could have been corrected. In reality, when analyzing the 
histology images, it is clear that such pressure was excessive. The tissue extends 
upwards into a dome-like shape. The dermis looks separated, with holes in between 
fibers and cells, and even intraepidermal blistering (Figure 30 c, d). This is also evident 
in the vimentin immunostaining images of Figure 31 b compared to the correct structure 
in the healthy model (a).  
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All in all, a high negative pressure of 65-70 kPa (the maximum capacity of our device) 
was proven to be excessive for the generation of a proper blister in RDEB models. The 
skin is fragile, and even though collagen VII is not present throughout the dermis, this 
experiment proves that its anchoring function plays a role in dermal integrity. However, 
for other less severe subtypes or different EB types (where the protein at fault plays 
another role, see Annex) it may be appropriate to use such magnitude.  
Experiment 2 introduced, for 7 minutes, 80-85 kPa of negative pressure. Applying a 
smaller force was thought to increase the chances of not ripping the dermis. Righteously 
so, when the histology samples were analyzed, the dermis looked as if it had suffered 
substantially less trauma. A blister can be distinguished at the dermal-epidermal junction 
(Figure 30 e), but, when analyzed closely, it is evident that it is part of the dermis, as 
some fibroblasts are present on the blister roof. In addition, other minor dermal blisters 
can be observed below, as consequence of the rupturing and destructuralization that the 
suction induced (as seen in vimentin study Figure 31 c).  
Finally, in experiment 3 the medium vacuum (80-85 kPa) was applied for 5 minutes. After 
analyzing the histology samples, it was clear these were the best conditions. In Figure 
30 f, the blister generated appears to be a clear separation of the epidermis from the 
dermis, as evidenced in the smooth joining at the two flanking sides. No fibroblasts 
appear still joined to the epidermis. The dermis is not torn in comparison with the other 
samples. Compared to the healthy subjects, the extracellular matrix looks slightly 
separated, if not almost intact, as it can be seen in the vimentin assay’s images from 
Figure 31 d. Consequently, it was concluded that the optimal conditions tested out in this 
work were those of Experiment 3. The pressure applied was enough to generate a 
delimited blister on the skin graft, but not too much so that damage was done. In the 
same manner, it was applied for a sufficient amount of time to obtain the proper results.  
Temperature played an important role in blister generation. As mentioned before, an 
increase in this parameter in the specific area stimulates the molecular processes that 
occur within it [48]. Therefore, the separation of epidermis and dermis at is produced by 
rupture of DEJ, benefited by heat. While suctioning of the skin provokes splitting by 
mechanical forces, temperature aids in formation of the desired blister. In a recent study 
assessing the potential of mesenchymal stem cell therapy in RDEB child patients, 
suction blisters were introduced to evaluate DEJ integrity before and after treatment [51]. 
A vacuum device was employed, set to deliver 12-15 mmHg (1.5-2 kPa) with heat being 
directly and constantly applied to the skin. Blistering times in patients were about 10 
minutes. Even though temperature values are not specified in the report, it can be 
extracted that this parameter influences the outcome significantly. This is indicated by 
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the fact that small blistering times, similar to those resulted in this work, are obtained with 
minimal pressure. Consequently, the proper temperature value, delivered in a non-
changing environment (the suction chamber) can substitute a higher suction force in 
generating blister for RDEB.  
The pressure ranges selected for all the experiments are consistent with the most recent 
study analyzed, from Stanford University researchers [52]. Similar blistering times were 
obtained, under a slightly lower negative pressure (5.7 min at approximately 91 kPa). 
The results are comparable to those obtained in this work, where a higher suction force 
(80-85 kPa) generated a blister in 5 minutes.  
In said research project, heat was delivered to the skin in a controlled way (heat ring at 
37 ºC). In the present work, temperature was not constant throughout the experiment, 
first applying it alone to warm up the skin, and then outside of the chamber during the 
suctioning process. Obtaining similar results with different temperature conditions 
suggests that, with high suction, temperature plays a secondary role in blister generation. 
Nevertheless, heat delivery should be improved for reproducibility of experiments in 
future work.  
The fact that at the same time, two completely independent research projects, with 
dissimilar instruments, obtained almost the same result proves up to a certain level that 
they are accurate. Furthermore, it is an indication of the significance of the research and 
how important it is to expand it.  
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6. CONCLUSIONS 
• As dermal-epidermal adherence is a decisive parameter on EB diagnosis, we 
have generated a precise device to substitute the current RDEB diagnostic 
method by a more precise, reproducible and reliable one.  
• An easy to use device represents a less invasive method of diagnosis that betters 
the life of patients that may have severe conditions such as RDEB. 
• The ideal combination of negative pressure and time to produce a proper blister 
in RDEB skin (mutation c.6527insC) is 80-85 kPa for 5 minutes.  
• The device can be implemented in different research projects, for example, to 
prove DEJ integrity in genetically corrected mice models. 
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7. LIMITATIONS AND FUTURE WORK 
 
The objectives of this work were positively achieved and have been presented 
throughout this thesis. Nevertheless, some limitations and improvements can and must 
be done to both the device and testing methodology.  
First and foremost, the device must be tested in patients, to eliminate the limitations that 
an animal model presents. Even though the human skin equivalents do achieve their 
purpose, tissue structures are missing from these models, such as other cell types, hair 
follicles, or sensory receptors. Disease characteristics may not be fully replicated as 
other factors influence DEJ integrity.  
As the clinical level cannot be easily reached, other methods must be applied to improve 
the work that has been done. Skin models from different patients must be generated, as 
genotypes are different within the same condition, and other optimal suction and time 
combinations may be found for RDEB. Healthy samples’ blistering times should be 
measured in further studies. Moreover, the device should be tested for other types and 
subtypes of EB. Different mutations give rise to the phenotypical heterogeneity of this 
disorder, with less severe conditions that will result in higher blistering times.  
Regarding the device, there are certain aspects that must be improved. It was generated 
as a first draft, to test the hypothesis. The objective was to create the tool keeping in 
mind that it would be bettered in future works. First, the heating mechanism should be 
further developed, by including a temperature sensor to have this data real-time on the 
screen, along with the pressure and time. Additionally, the heating mechanism can be 
substituted by a specialized heating component. This could be introduced inside the 
suction chamber that is in contact with the skin. In that way, the heat is delivered directly 
to the selected area by convection while applying the negative pressure, and the effect 
of temperature in blister generation would be more effective. For future development of 
the device, the incandescent light bulb should be changed, as there is a risk of it breaking 
and damaging the patient (in this case, the animal model).  
Finally, the accuracy of the current pressure sensor should be assessed. As seen in 
Figure 28: Voltage signal from the pressure sensor., the readings from this component 
vary in time. A mean of the values registered during blistering time could be obtained 
and delivered in the screen at the end.  
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8. REGULATORY FRAMEWORK AND SOCIOECONOMIC 
IMPACT 
 
8.1. Regulatory Framework 
The device developed in this work falls into the category of Class IIa active medical 
devices intended to be used transiently as a diagnostic tool  according to the Regulation 
(EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical 
devices [62]. It is important to keep in mind that for further development and fabrication 
of such devices, extensive quality controls must be followed during every step of the 
process. However, the product developed in this work is only applied for research (at the 
moment), and it is not subjected to these rules. Annex XV of this regulation lists the 
aspects that may directly affect research-only medical devices. Valid methodologies that 
are adapted to the device and the clinical outcome must be applied and addressed.  
The skin equivalents developed in this work are included in the category of human skin 
models. According to the European Medicines Agency (EMA), these products are 
classified as tissue-engineered and cell therapy products, inside the category of 
Advanced Therapy Medicinal Products (ATMP). Such classification is dictated by the 
European Parliament Regulation (CE) Nº 1394/2007. Their application for translation into 
clinical use (clinical trials) must be regulated by the Good Manufacturing Procedures 
(GMP) guidelines, which are listed by the European Commission [63]. In this work the 
skin models were fabricated for research purposes only, so the GMPs did not need to be 
followed. However, the current laboratory biosafety regulations of Class II Biological 
Safety, listed in the Royal Decree 664/1997 and the European Parliament Directive 
2000/54/CE, were followed during the whole research process.  
The human skin equivalents grafted into mice were handled and developed under the 
proper regulations as well. Immunodeficient mice from the CIEMAT Laboratory Animals 
Facility (Spanish registration 28079-21) were housed in a pathogen-free environment 
following the European and Spanish regulations (Spanish R.D. 223/88 and O.M. 13-10-
89 of the Ministry of Agricultural, Food and Fisheries, protection and use of animals in 
scientific research and internal biosafety and bioethics guidelines. European Convention 
123 on use and protection of vertebrate mammals in experimentation and other scientific 
purposes). The skin models were made according to the procedure described under the 
patent WO2015173206 registered in 2015 by BioDan Group.  
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8.2. Socioeconomic Impact 
This work introduces an important advance in the future diagnosis of EB. The principal 
characteristic of the developed device is its reduced size and manageability in 
comparison with other similar suction devices available for this purpose. This implies a 
significative cost reduction in materials, components, and general manufacturing, 
maintenance and repair. Hence, the applications in research and clinical fields could be 
considerably benefited in both the economic aspect and ease of use. Moreover, for future 
direct use on patients, it would imply a less invasive and painful diagnostic method, as 
there is no need for it to be attached to the skin for a long time. The applications in 
research are many, one of them explored in this work. To assess the results of gene 
editing approaches, having more parameters of the disease can verify the correction of 
the gene.  
As it has been already mentioned, the impact in the field of Epidermolysis bullosa as a 
rare disease is important in several levels. Any progress made to make the lives of these 
patients easier is deeply significative. Additionally, the impact of such advances is related 
to the economy as well. Reducing diagnostic procedures lowers costs for both patients 
and the administration. The costs of the project are exposed in the following Tables 4 
and 5. They have been divided on two parts: expenses of the device and of the skin 
models. As it can be seen, the total cost is around 970 €.  
Table 4: Expenses of suction device. Costs per unit and total cost displayed. 
Suction Device 
Material Units Cost per unit (€) Total (€) 
Blackhead Remover 1 20 20 
Arduino-compatible Microcontroller 3 3.66 10.99 
0.96” OLED Display 1 7.49 7.49 
Incandescent Light Bulb 1 0.50 0.50 
Pressure Sensor MPX4115A 1 17.82 17.82 
Power Supply  1 10.99 10.99 
Potentiometer 1 0.20 0.20 
Pushbutton 1 0.30 0.30 
Transistor BC547 1 0.20 0.20 
Transistor TIP41 1 0.30 0.30 
Resistor 220  3 0.05 0.15 
Capacitor 1 0.20 0.20 
Diode 1 0.50 0.50 
Cable (10 m) 0.1 2.50 0.25 
Solder 0.01 20 0.2 
 
  Total Cost (€) 70.09 
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Table 5: Skin models expenses. Includes materials and reagents used in the experiments and laboratory 
equipment. Costs per unit and total cost displayed. 
Skin Models 
Experimental Materials 
Material Units Cost per unit (€) Total (€) 
DMEM 500 ml 5 27 135 
Fetal Bovine Serum (FBS) 50 ml 0.5 32 16 
Antibiotic/Antimicotic solution 100 ml 0.25 31.95 7.99 
Trypsin 100 ml 1 15 15 
Phosphate Buffered Saline (PBS) 500 ml 2 17 34 
Tranexamic Acid 10 ml 0.01 314 3.14 
Anti-Collagen VII 100 μl 0.05 289 14.45 
Anti-Vimentin 100 μl 0.05 328 16.4 
Anti-Keratin 10 100 μl 0.05 344 17.2 
Anti-Keratin 14 100 μl 0.05 368 18.4 
Secondary antibody 100 μl 0.1 340 34 
ABC Kit 0.01 423.60 4.24 
DAB Kit 0.01 152 1.52 
 
Laboratory Equipment and Disposables 
Material Units Cost per unit (€) Total (€) 
Glass slides Thermo Scientific 2.5 80 200 
2 ml stripette (200 pack) 2 67 134 
5 ml stripette (200 pack) 2 67 134 
10 ml stripette (200 pack) 0.5 67 33.5 
15 ml tube (200 pack) 100 0.22 22 
50 ml tube (200 pack) 50 0.24 12 
1.5 ml Eppendorf tube (500 pack) 1 45 45 
6-well plate (50 pack) 0.1 132 13.2 
75 cm2 culture flask (20 pack) 3 40 120 
Filtration unit 250 ml (12 pack) 0.8 90.95 72.76 
Nitrile gloves (100 pack) 2 9.68 19.36 
    
  Total Cost (€) 901 
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ANNEX 
Epidermolysis bullosa types and subtypes. Includes inheritance patterns (AR: autosomal 
recessive; AD: autosomal dominant), mutated genes and affected proteins of each. [17] 
EB (sub-) type Inheritance Mutated gene Affected protein 
Epidermolysis bullosa simplex, EBS (intradermal [epidermolytic] blisters) 
Suprabasal EBS (cytolysis of suprabasal keratinocytes) 
Acral peeling skin syndrome AR TGM5 Transglutaminase-5 
Superficial EBS AD ? ? 
Acantholytic EBS (includesvariants formerly 
termed lethal acantholytic EBS and lethal 
congenital EBS) 
AR DSP, JUP 
Desmoplakin, 
plakoglobin 
Skin fragility syndromes (very rare variants) 
Desmoplakin deficiency (skin fragility/woolly 
hair syndrome) 
AR DSP Desmoplakin 
Plakoglobin deficiency AR JUP Plakoglobin 
Plakophilin deficiency (skin 
fragility/ectodermal dysplasia syndrome) 
AR PKP1 Plakophilin1 
Basal EBS (cytolysis of basal keratinocytes) 
Localized EBS (formerly type Webwer-
Cockayne) 
AD KRT5, KRT14 Keratin 5, keratin 14 
Generalized severe EBS (formerly type 
Dowling-Meara, herpetiform EBS) 
AD KRT5, KRT14 Keratin 5, keratin 14 
Generalized intermediate EBS (formerly 
EBS, generalized-other; non-Dowling-Meara; 
EBS, type Koebner) 
AD 
KRT5, KRT14, 
COL17A1 
Keratin 5, keratin 14, 
type XVII collagen 
EBS with mottled pigmentation AD KRT5 Keratin 5 
EBS with migratory circinate erythema AD KRT5 Keratin 5 
Autosomal-recesive EBS K14 AR KRT14 Keratin 14 
Trauma-induced skin blistering AR EXPH5 Exophilin-5 
EBS with muscle dystrophy AR PLEC1 Plectin 
EBS with pyloric atresia AR 
PLEC1, ITGA6, 
ITGB4 
Plectin, integrin α6, 
integrin β4 
EBS type Ogna AD PLEC1 Plectin 
Autosomal-recessive EBS, BP230 deficiency AR DST 
Bullous pemphigoid 
antigen 1 (BP230) 
Autosomal-recessive EBS, exophilin-5 
deficiency 
AR EXPH5 Exophilin 5 
Junctional epidermolysis bullosa, JEB (junctional [lucidolytic] blisters within the 
basement membrane zone) 
Generalized JEB 
Generalized severe JEB (previously type 
Herlitz) 
AR 
LAMA3, 
LAMB3, LAMC2 
Laminin α3, β3, γ2 
laminin 332 chain 
  
 
Generalized intermediate JEB (formerly type 
non-Herlitz; JEB, generalized other; GABEB) 
AR 
LAMA3, 
LAMB3, LAMC2 
Laminin α3, β3, γ2 
laminin 332 chain 
JEB with pyloric atresia AR ITGA6, ITGB4 
Integrin α6, integrin 
β4 
JEB, late onset (formerly progressive) AR COL17A1 Type XVII collagen 
Localized JEB AR COL17A1 Type XVII collagen 
JEB with respiratory and renal involvement 
(previously EB congenital nephrotic 
syndrome-interstitial lung disease) 
AR ITGA3 Integrin A3 
Localized JEB 
Localized JEB (previously localized JEB, 
non-Herlitz) 
AD COL17A1 Type XVII collagen 
JEB inversa AR 
LAMA3, 
LAMB3, LAMC2 
Laminin α3, β3, γ2-
chains of laminin 332 
JEB, laryngo-onycho-cutaneous syndromes AR LAMA3A 
Laminin α3a chain of 
laminin332 
Dystrophic epidermolysis bullosa, DEB (dermolytic blistering below the lamina densa) 
Dominant DEB 
Generalized dominant DEB (formerly type 
Pasini, Cockayne-Touraine) 
AD COL7A1 Type VII collagen 
Acral dominant DEB AD, AR COL7A1 Type VII collagen 
Pretibial dominant DEB AD, AR COL7A1 Type VII collagen 
Dominant DEB pruriginosa AD, AR COL7A1 Type VII collagen 
Dominant DEB, nails only AD COL7A1 Type VII collagen 
Dominant DEB, bullous dermolysis of the 
new born 
AD, AR COL7A1 Type VII collagen 
Recessive DEB 
Generalized severe DEB (formerly type 
Hallopeau-Siemens) 
AR COL7A1 Type VII collagen 
Generalized intermediate DEB (formerly type 
non-Hallopeau-Siemens; RDEB, generalized 
other) 
AR COL7A1 Type VII collagen 
Recessive DEB inversa AR COL7A1 Type VII collagen 
Localized recessive DEB (formerly acral 
recessive DEB) 
AR COL7A1 Type VII collagen 
Pretibial recessive DEB AD, AR COL7A1 Type VII collagen 
Recessive DEB pruriginosa AR COL7A1 Type VII collagen 
Recessive DEB (centripetal variant) AR COL7A1 Type VII collagen 
Recessive DEB, bullous dermolysis of the 
newborn 
AR COL7A1 Type VII collagen 
Kindler syndrome (intraepidermal, 
junctional or sub-lamina-densa blisters 
AR 
FERMT1 
(KIND1) 
Fermitin family homo-
log 1 protein (kindlin-
1) 
 
 
